The Romanian translation and validation of the Extended Prostate Cancer Index Composite in patients undergoing radical prostatectomy
- PMID: 39234449
- PMCID: PMC11370850
- DOI: 10.15386/mpr-2757
The Romanian translation and validation of the Extended Prostate Cancer Index Composite in patients undergoing radical prostatectomy
Abstract
Background and aims: To evaluate the quality of life in patients treated for prostate cancer in detail, an accessible, extensive, and easy-to-administer questionnaire is needed. The self-administered 50-item "Expanded Prostate Cancer Index Composite" (EPIC) is an instrument used for this purpose, but it is not officially translated into Romanian. The aim of the study was to translate and validate the Romanian version of the EPIC.
Methods: We translated and culturally adapted the EPIC into Romanian. For validation, we included a retrospective analysis of 112 patients who underwent robotic radical prostatectomy and a prospective study including 120 consecutive patients hospitalized before surgical treatment. Baseline and follow-up assessments took place before and at six months, two, and five years post-surgery, between January 2014 and December 2015. We performed cross-sectional correlations between the EPIC, AUASI, and SF-12 at baseline, factor analysis, and calculated the internal consistency.
Results: For most EPIC domains and subscales, our a priori-defined criteria for reliability were fulfilled (Cronbach's alpha 0.7-0.9). Cross-sectional correlations between EPIC scales and AUASI domain ranged from 0.23-0.69, and SF-12 domains ranged from 0.21-0.53 and 0.22-0.61, respectively. The retrospective analysis showed a medium acceptability and understanding of the EPIC questionnaire. In the prospective study, the revised EPIC draft showed an overall higher acceptability with a responding rate of 66% at a 5-year follow-up. All domains exhibited good internal consistency except for the hormonal section (Cronbach's α = 0.67) at the 6-month follow-up.
Conclusion: The Romanian version of the EPIC is reliable, responsive and valid for measuring HRQL in prostate cancer patients. The EPIC questionnaire proved to be an exhaustive and reproducible instrument for evaluating the quality of life in Romanian prostate cancer patients.
Keywords: prostate cancer; quality of life; radical prostatectomy; translation; validation.
Figures
Similar articles
-
The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation.Health Qual Life Outcomes. 2018 Feb 20;16(1):36. doi: 10.1186/s12955-018-0859-1. Health Qual Life Outcomes. 2018. PMID: 29458434 Free PMC article.
-
Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP): psychometric validation and prospective application for early functional outcomes at a single institution.BMC Urol. 2020 Oct 20;20(1):163. doi: 10.1186/s12894-020-00734-y. BMC Urol. 2020. PMID: 33081748 Free PMC article.
-
Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.Urology. 2010 Nov;76(5):1245-50. doi: 10.1016/j.urology.2010.01.027. Epub 2010 Mar 28. Urology. 2010. PMID: 20350762 Free PMC article.
-
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.Eur Urol Oncol. 2022 Apr;5(2):153-163. doi: 10.1016/j.euo.2021.10.004. Epub 2021 Nov 14. Eur Urol Oncol. 2022. PMID: 34785188
-
Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments.BJU Int. 2017 Oct;120(4):468-481. doi: 10.1111/bju.13896. Epub 2017 May 30. BJU Int. 2017. PMID: 28437031 Review.
References
-
- Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71:618–629. - PubMed
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, et al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2206–2216. - PubMed
-
- Bullinger M. Quality of life - definition, conceptualization and implications - a methodologist view. Theoretic Surgery. 1991;6:143–148.
LinkOut - more resources
Full Text Sources